










<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/css" href="http://52.214.119.220/wiki/skins/common/feed.css?97"?>
<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/">
	<channel>
		<title>User:Ophelie Lefort/Sandbox - Revision history</title>
		<link>http://52.214.119.220/wiki/index.php?title=User:Ophelie_Lefort/Sandbox&amp;action=history</link>
		<description>Revision history for this page on the wiki</description>
		<language>en</language>
		<generator>MediaWiki 1.11.2</generator>
		<lastBuildDate>Fri, 10 Apr 2026 21:33:09 GMT</lastBuildDate>
		<item>
			<title>Ophelie Lefort at 16:44, 27 January 2017</title>
			<link>http://52.214.119.220/wiki/index.php?title=User:Ophelie_Lefort/Sandbox&amp;diff=2712758&amp;oldid=prev</link>
			<description>&lt;p&gt;&lt;/p&gt;

			&lt;table style=&quot;background-color: white; color:black;&quot;&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;tr&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;←Older revision&lt;/td&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;Revision as of 16:44, 27 January 2017&lt;/td&gt;
			&lt;/tr&gt;
		&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 40:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 40:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;A disorder of neutrophil serine proteases has also been demonstrated in many genetic disorders like Higashi syndrome or Papillon-Lefevre syndrome.&amp;lt;ref&amp;gt;Tailor-made inflammation: how neutrophil serine proteases modulate the inflammatory response&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;A disorder of neutrophil serine proteases has also been demonstrated in many genetic disorders like Higashi syndrome or Papillon-Lefevre syndrome.&amp;lt;ref&amp;gt;Tailor-made inflammation: how neutrophil serine proteases modulate the inflammatory response&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Kai Kessenbrock,corresponding author1 Therese Dau,2 and Dieter E. Jenne2 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3016231/#CR2&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Kai Kessenbrock,corresponding author1 Therese Dau,2 and Dieter E. Jenne2 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3016231/#CR2&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</description>
			<pubDate>Fri, 27 Jan 2017 16:44:29 GMT</pubDate>			<dc:creator>Ophelie Lefort</dc:creator>			<comments>http://52.214.119.220/wiki/index.php/User_talk:Ophelie_Lefort/Sandbox</comments>		</item>
		<item>
			<title>Ophelie Lefort at 16:43, 27 January 2017</title>
			<link>http://52.214.119.220/wiki/index.php?title=User:Ophelie_Lefort/Sandbox&amp;diff=2712757&amp;oldid=prev</link>
			<description>&lt;p&gt;&lt;/p&gt;

			&lt;table style=&quot;background-color: white; color:black;&quot;&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;tr&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;←Older revision&lt;/td&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;Revision as of 16:43, 27 January 2017&lt;/td&gt;
			&lt;/tr&gt;
		&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 1:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 1:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;==Neutrophil Serine 4 or Serine Protease 57 (4Q7X)==&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;==Neutrophil Serine 4 or Serine Protease 57 (4Q7X)==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;lt;StructureSection load='4Q7X' size='350' side='right' caption='[[4Q7X]], [[Resolution|resolution]] 2.55&amp;amp;Aring;' scene=''&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;lt;StructureSection load='4Q7X' size='350' side='right' caption='[[4Q7X]], [[Resolution|resolution]] 2.55&amp;amp;Aring;' scene=''&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;NSP4 also called Neutrophil Serine 4 (NSP4) or Serine Protease 57 (PRSS57),is member of the peptidase S1 family of proteins.  It is one of the neutrophil serine protease in the cytoplasmic granules of neutrophils. This enzyme is expressed in bone marrow and takes part of the immune response against pathogens. NSP4 is located in the telomeric region of the chromosome 19. The protein cleaves preferentially after Arg residues but also after citrulline and methylarginie residues.&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;NSP4 also called Neutrophil Serine 4 (NSP4) or Serine Protease 57 (PRSS57), is &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;a &lt;/ins&gt;member of the peptidase S1 family of proteins.  It is one of the neutrophil serine protease in the cytoplasmic granules of neutrophils. This enzyme is expressed in bone marrow and takes part of the immune response against pathogens. NSP4 is located in the telomeric region of the chromosome 19. The protein cleaves preferentially after Arg residues but also after citrulline and methylarginie residues.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;==Function==&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;==Function==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Recruitement of neutrophils to the site of inflammation is the earliest defense reaction against pathogens. NSP4 is stored in the azurophilic granules &amp;lt;ref&amp;gt;PMID:23904161&amp;lt;/ref&amp;gt; which is a compartment of neutrophils. In response to neutrophil activation, NSP4 is released into the pericellular environment where microbes are after their phagocytosis. The serine protease 54 &lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;not &lt;/del&gt;only kill pathogens but also &lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;regulate &lt;/del&gt;the activity of immune mediators such as chemokines and lymphocytes. &amp;lt;ref&amp;gt;NSP4, an elastase-related protease in human neutrophils with arginine specificity&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Recruitement of neutrophils to the site of inflammation is the earliest defense reaction against pathogens. NSP4 is stored in the azurophilic granules &amp;lt;ref&amp;gt;PMID:23904161&amp;lt;/ref&amp;gt; which is a compartment of neutrophils. In response to neutrophil activation, NSP4 is released into the pericellular environment where microbes are after their phagocytosis. The serine protease 54 &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;doesn't &lt;/ins&gt;only kill pathogens but also &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;regulates &lt;/ins&gt;the activity of immune mediators such as chemokines and lymphocytes. &amp;lt;ref&amp;gt;NSP4, an elastase-related protease in human neutrophils with arginine specificity&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Natascha C. Perera,a Oliver Schilling,b Heike Kittel,a Walter Back,c Elisabeth Kremmer,d and Dieter E. Jenne https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3341072/&amp;lt;/ref&amp;gt; NSP4 alterates chemokines by proteolitically cleaving N-terminus of the chemokine.&amp;lt;ref&amp;gt;ailor-made inflammation: how neutrophil serine proteases modulate the inflammatory response&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Natascha C. Perera,a Oliver Schilling,b Heike Kittel,a Walter Back,c Elisabeth Kremmer,d and Dieter E. Jenne https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3341072/&amp;lt;/ref&amp;gt; NSP4 alterates chemokines by proteolitically cleaving N-terminus of the chemokine.&amp;lt;ref&amp;gt;ailor-made inflammation: how neutrophil serine proteases modulate the inflammatory response&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Kai Kessenbrock,corresponding author1 Therese Dau,2 and Dieter E. Jenne2 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3016231/&amp;lt;/ref&amp;gt; Furthermore, the caspase-like activity of PRSS57 can activate lymphocytes and the adaptive immune response. However, although NSP4 can inactivate some inflammatory processes, the neutrophil serine protease generally promotes than inhibits the inflammatory response.&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Kai Kessenbrock,corresponding author1 Therese Dau,2 and Dieter E. Jenne2 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3016231/&amp;lt;/ref&amp;gt; Furthermore, the caspase-like activity of PRSS57 can activate lymphocytes and the adaptive immune response. However, although NSP4 can inactivate some inflammatory processes, the neutrophil serine protease generally promotes &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;rather &lt;/ins&gt;than inhibits the inflammatory response.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== Structural highlights ==&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== Structural highlights ==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;The protein has a 283 amino-acids long sequence with two mainly domains [[Image:Linear structure of PRSS57.png | thumb]]. It forms a kind of elongate sphere of approximately 70Å large and 150Å long (dimensions: 70,37Å X 70,37Å X 105,02Å). The protein is composed of signal peptide (1-31) which leads to the location in &lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;azurophil &lt;/del&gt;granules &amp;lt;ref&amp;gt;NSP4 Is Stored in Azurophil Granules and Released by Activated Neutrophils as Active Endoprotease with Restricted Specificity&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;The protein has a 283 amino-acids long sequence with two mainly domains [[Image:Linear structure of PRSS57.png | thumb]]. It forms a kind of elongate sphere of approximately 70Å large and 150Å long (dimensions: 70,37Å X 70,37Å X 105,02Å). The protein is composed of signal peptide (1-31) which leads to the location in &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;azurophilic &lt;/ins&gt;granules &amp;lt;ref&amp;gt;NSP4 Is Stored in Azurophil Granules and Released by Activated Neutrophils as Active Endoprotease with Restricted Specificity&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Natascha C. Perera, Karl-Heinz Wiesmüller, Maria Torp Larsen, Beate Schacher, Peter Eickholz, Niels Borregaard and Dieter E. Jenne DOI: https://doi.org/10.4049/jimmunol.1301293 &amp;lt;/ref&amp;gt; and allows its excretion. In addition there is a protease domain (32-283) which is a trypsin-like domain with a trypsin-like &amp;lt;scene name='75/751133/Active_site/1'&amp;gt;active site&amp;lt;/scene&amp;gt; , according to the specificity for P1-Arg residues, but this domain can be an elastase-like active site according to the primary sequence (because of the presence of a swallow S1 pocket) specific to small aliphatic residues.&amp;lt;ref&amp;gt;S.. Jack Lin, Ken C. Dong, Charles Eigenbrot, Menno van Lookeren Campagne, Daniel Kirchhofer Structures of Neutrophil Serine Protease 4 Reveal an Unusual Mechanism of Substrate Recognition by a Trypsin-Fold Protease DOI: http://dx.doi.org/10.1016/j.str.2014.07.008&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Natascha C. Perera, Karl-Heinz Wiesmüller, Maria Torp Larsen, Beate Schacher, Peter Eickholz, Niels Borregaard and Dieter E. Jenne DOI: https://doi.org/10.4049/jimmunol.1301293 &amp;lt;/ref&amp;gt; and allows its excretion. In addition there is a protease domain (32-283) which is a trypsin-like domain with a trypsin-like &amp;lt;scene name='75/751133/Active_site/1'&amp;gt;active site&amp;lt;/scene&amp;gt; , according to the specificity for P1-Arg residues, but this domain can be an elastase-like active site according to the primary sequence (because of the presence of a swallow S1 pocket) specific to small aliphatic residues.&amp;lt;ref&amp;gt;S.. Jack Lin, Ken C. Dong, Charles Eigenbrot, Menno van Lookeren Campagne, Daniel Kirchhofer Structures of Neutrophil Serine Protease 4 Reveal an Unusual Mechanism of Substrate Recognition by a Trypsin-Fold Protease DOI: http://dx.doi.org/10.1016/j.str.2014.07.008&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;The &amp;lt;scene name='75/751133/Active_site/1'&amp;gt;active site&amp;lt;/scene&amp;gt; is form by 4 amino acids: Gly(189), Phe(190), Ser(216), D(226)&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;The &amp;lt;scene name='75/751133/Active_site/1'&amp;gt;active site&amp;lt;/scene&amp;gt; is form by 4 amino acids: Gly(189), Phe(190), Ser(216), D(226)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;The residue F190 obstructs the active site which &lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;could &lt;/del&gt;normally &lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;not links &lt;/del&gt;a P1-Arg. However, a study &amp;lt;ref&amp;gt;Natascha C. Perera, Karl-Heinz Wiesmüller, Maria Torp Larsen, Beate Schacher, Peter Eickholz, Niels Borregaard and Dieter E. Jenne NSP4 Is Stored in Azurophil Granules and Released by Activated Neutrophils as Active Endoprotease with Restricted Specificity  DOI: https://doi.org/10.4049/jimmunol.1301293&amp;lt;/ref&amp;gt; &lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;considered &lt;/del&gt;the possibility that the two residues S216 and F190 of the active site can form a flexible gate which allows P1-Arg to enter. Then, the link between the active site and P1-Arg can be stabilized by a salt bridge interaction between S1-D226 and P1-Arg.&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;The residue F190 obstructs the active site which normally &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;couldn't link &lt;/ins&gt;a P1-Arg. However, a study &amp;lt;ref&amp;gt;Natascha C. Perera, Karl-Heinz Wiesmüller, Maria Torp Larsen, Beate Schacher, Peter Eickholz, Niels Borregaard and Dieter E. Jenne NSP4 Is Stored in Azurophil Granules and Released by Activated Neutrophils as Active Endoprotease with Restricted Specificity  DOI: https://doi.org/10.4049/jimmunol.1301293&amp;lt;/ref&amp;gt; &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;considers &lt;/ins&gt;the possibility that the two residues S216 and F190 of the active site can form a flexible gate which allows P1-Arg to enter. Then, the link between the active site and P1-Arg can be stabilized by a salt bridge interaction between S1-D226 and P1-Arg.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;The hypothesis of the flexible gate &lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;was &lt;/del&gt;confirmed by the same study. The mutations of S216 only, F190 only or both together show a forced full open gate is more efficient than a forced partially open gate.&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;The hypothesis of the flexible gate &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;is &lt;/ins&gt;confirmed by the same study. The mutations of S216 only, F190 only or both together show a forced full open gate is more efficient than a forced partially open gate.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;The conclusion is that the protease domain is a trypsin-like domain.[[Image:Active site.jpg | thumb]]&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;The conclusion is that the protease domain is a trypsin-like domain.[[Image:Active site.jpg | thumb]]&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 23:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 23:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== Interaction ==&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== Interaction ==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;Like &lt;/del&gt;in other trypsin-like proteases &amp;lt;scene name='75/751133/F190/1'&amp;gt;D226&amp;lt;/scene&amp;gt; is inaccessible to the substrate but helps stabilize the closed S1 pocket by forming an H-bond with the &amp;lt;scene name='75/751133/F190/1'&amp;gt;F190&amp;lt;/scene&amp;gt; amide.&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;As &lt;/ins&gt;in other trypsin-like proteases&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;, &lt;/ins&gt;&amp;lt;scene name='75/751133/F190/1'&amp;gt;D226&amp;lt;/scene&amp;gt; is inaccessible to the substrate but helps stabilize the closed S1 pocket by forming an H-bond with the &amp;lt;scene name='75/751133/F190/1'&amp;gt;F190&amp;lt;/scene&amp;gt; amide.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;NSP4 compared to the other trypsin-like proteases has some specificity as the arginine side chain movement from the canonical &amp;quot;down&amp;quot; to the noncanonical &amp;quot;up&amp;quot; position in NSP4, which is accomplished by a rotation of the Chi2 angle by 160°&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;, this &lt;/del&gt;is possible thanks to &amp;lt;scene name='75/751133/F190/1'&amp;gt;F190&amp;lt;/scene&amp;gt; which provides a hydrophobic platform that interacts with the aliphatic portion of the P1-arginine side chain. All other residue positions are preserved. The specificity for P1-arginine is &lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;conferred &lt;/del&gt;by H-bonds between guanidinium group and &amp;lt;scene name='75/751133/H_bounds/1'&amp;gt;three H-bonds acceptors (S216, S192, G217)&amp;lt;/scene&amp;gt;. This specificity allows NSP4 to cleave citrulline&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;, &lt;/del&gt;which is not cleaved by other trypsin-like proteases because of its non-charged propriety&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;, &lt;/del&gt;and the impossibility to do salt-bridges. Other trypsin-like proteases are not able to cleave methylarginine &lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;neither &lt;/del&gt;because of a steric clash with the methyl group&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;, which &lt;/del&gt;is not an issue for NSP4 since the methyl group is exposed to the solvent. The capacity to cleave &lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;these &lt;/del&gt;post-translationally modified arginine utility may be to act against microbial and virulence factors containing modified arginine or to interact with chemokines. &amp;lt;ref&amp;gt;Lin, S. Jack, Ken C. Dong, Charles Eigenbrot, Menno van Lookeren Campagne, and Daniel Kirchhofer. “Structures of Neutrophil Serine Protease 4 Reveal an Unusual Mechanism of Substrate Recognition by a Trypsin-Fold Protease.” Structure 22, no. 9 (September 2, 2014): 1333–40.[http://dx.doi.org/10.1016/j.str.2014.07.008]&amp;lt;/ref&amp;gt; &lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;NSP4 compared to the other trypsin-like proteases has some specificity as the arginine side chain movement from the canonical &amp;quot;down&amp;quot; to the noncanonical &amp;quot;up&amp;quot; position in NSP4, which is accomplished by a rotation of the Chi2 angle by 160°&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;. This &lt;/ins&gt;is possible thanks to &amp;lt;scene name='75/751133/F190/1'&amp;gt;F190&amp;lt;/scene&amp;gt; which provides a hydrophobic platform that interacts with the aliphatic portion of the P1-arginine side chain. All other residue positions are preserved. The specificity for P1-arginine is &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;given &lt;/ins&gt;by H-bonds between guanidinium group and &amp;lt;scene name='75/751133/H_bounds/1'&amp;gt;three H-bonds acceptors (S216, S192, G217)&amp;lt;/scene&amp;gt;. This specificity allows NSP4 to cleave citrulline which is not cleaved by other trypsin-like proteases&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;, &lt;/ins&gt;because of its non-charged propriety and the impossibility to do salt-bridges. Other trypsin-like proteases are not able to cleave methylarginine because of a steric clash with the methyl group&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;. This &lt;/ins&gt;is not an issue for NSP4 since the methyl group is exposed to the solvent. The capacity to cleave &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;this &lt;/ins&gt;post-translationally modified arginine utility may be to act against microbial and virulence factors containing modified arginine or to interact with chemokines. &amp;lt;ref&amp;gt;Lin, S. Jack, Ken C. Dong, Charles Eigenbrot, Menno van Lookeren Campagne, and Daniel Kirchhofer. “Structures of Neutrophil Serine Protease 4 Reveal an Unusual Mechanism of Substrate Recognition by a Trypsin-Fold Protease.” Structure 22, no. 9 (September 2, 2014): 1333–40.[http://dx.doi.org/10.1016/j.str.2014.07.008]&amp;lt;/ref&amp;gt; &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt; &lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt; &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;lt;scene name='75/751133/Signal_peptide/1'&amp;gt;N terminus of NSP4&amp;lt;/scene&amp;gt; has been shown to be cleaved off by Cathepsin C and occurs during the translocation into the endoplasmic reticulum before the enzyme is stored in cytoplasmic granules. Natural serine protease inhibitors of NSP4 are present in human plasma and can form covalent NSP4-serpin complexes in vitro (&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;antithrombin &lt;/del&gt;for example which &lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;act &lt;/del&gt;as a suicide substrate with NSP4). However, in vivo, antithrombin can not trap NSP4 because of the presence of other neutrophil proteases.&amp;lt;ref&amp;gt;Perera, Natascha C., Karl-Heinz Wiesmüller, Maria Torp Larsen, Beate Schacher, Peter Eickholz, Niels Borregaard, and Dieter E. Jenne. “NSP4 Is Stored in Azurophil Granules and Released by Activated Neutrophils as Active Endoprotease with Restricted Specificity.” The Journal of Immunology 191, no. 5 (September 1, 2013) [https://doi.org/10.4049/jimmunol.1301293]&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;lt;scene name='75/751133/Signal_peptide/1'&amp;gt;N terminus of NSP4&amp;lt;/scene&amp;gt; has been shown to be cleaved off by Cathepsin C and occurs during the translocation into the endoplasmic reticulum before the enzyme is stored in cytoplasmic granules. Natural serine protease inhibitors of NSP4 are present in human plasma and can form covalent NSP4-serpin complexes in vitro (for example &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;antithrombin &lt;/ins&gt;which &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;acts &lt;/ins&gt;as a suicide substrate with NSP4). However, in vivo, antithrombin can not trap NSP4 because of the presence of other neutrophil proteases.&amp;lt;ref&amp;gt;Perera, Natascha C., Karl-Heinz Wiesmüller, Maria Torp Larsen, Beate Schacher, Peter Eickholz, Niels Borregaard, and Dieter E. Jenne. “NSP4 Is Stored in Azurophil Granules and Released by Activated Neutrophils as Active Endoprotease with Restricted Specificity.” The Journal of Immunology 191, no. 5 (September 1, 2013) [https://doi.org/10.4049/jimmunol.1301293]&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== Disease ==&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== Disease ==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;Granulocytes neutrophils &lt;/del&gt;are the most abundant leukocytes in the blood and are implicated in the immune system. They are the first defend barriers in the innate immunity. When a pathogen agent enters into the body, they recognize it thanks to its antigens and phagocyte the pathogen. They are quick &lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;and &lt;/del&gt;their recognition is non-specific&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;, &lt;/del&gt;and not dependent on previous exposure to microorganisms.&amp;lt;ref&amp;gt;Role of neutrophils in innate immunity: a systems biology-level approach.&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;Neutrophils &lt;/ins&gt;are the most abundant leukocytes in the blood and are implicated in the immune system. They are the first defend barriers in the innate immunity. When a pathogen agent enters into the body, they recognize it thanks to its antigens and phagocyte the pathogen. They are quick&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;, &lt;/ins&gt;their recognition is non-specific and not dependent on previous exposure to microorganisms.&amp;lt;ref&amp;gt;Role of neutrophils in innate immunity: a systems biology-level approach.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Kobayashi SD1, DeLeo FR. https://www.ncbi.nlm.nih.gov/pubmed/20836000&amp;lt;/ref&amp;gt; It has also been shown that neutrophils have not only a phagocyte role but can influence all the innate and adaptive immune response by exchanging information with the other immune cells through soluble mediators or direct cell contact.&amp;lt;ref&amp;gt;Neutrophils: Their Role in Innate and Adaptive Immunity&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Kobayashi SD1, DeLeo FR. https://www.ncbi.nlm.nih.gov/pubmed/20836000&amp;lt;/ref&amp;gt; It has also been shown that neutrophils have not only a phagocyte role but can influence all the innate and adaptive immune response by exchanging information with the other immune cells through soluble mediators or direct cell contact.&amp;lt;ref&amp;gt;Neutrophils: Their Role in Innate and Adaptive Immunity&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Carlos Rosales, 1 , * Nicolas Demaurex, 2 Clifford A. Lowell, 3 and Eileen Uribe-Querol 4  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4783580/&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Carlos Rosales, 1 , * Nicolas Demaurex, 2 Clifford A. Lowell, 3 and Eileen Uribe-Querol 4  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4783580/&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;In this &lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;manner&lt;/del&gt;, deficiency in NSP4 might &lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;lead &lt;/del&gt;to &lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;neutrophil &lt;/del&gt;deficiency and &lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;have &lt;/del&gt;terrible consequences. Unfortunately, NP4 is not the more important serin protease of neutrophils, so there isn’t currently in vivo studies of the release of the protein&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;, and any &lt;/del&gt;disease &lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;as &lt;/del&gt;yet been associated with a NSP4 dysfunction.&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;In this &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;way&lt;/ins&gt;, deficiency in NSP4 might &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;leads &lt;/ins&gt;to &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;neutrophils &lt;/ins&gt;deficiency and &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;has &lt;/ins&gt;terrible consequences. Unfortunately, NP4 is not the more important serin protease of neutrophils, so there isn’t currently in vivo studies of the release of the protein&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;. Any &lt;/ins&gt;disease &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;has &lt;/ins&gt;yet been associated with a NSP4 dysfunction.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Nevertheless, many studies have been released on the three most important neutrophil serin &lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;protease&lt;/del&gt;: neutrophil elastase (NE), cathepsin G (CG)&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;, &lt;/del&gt;and proteinase 3 (PR3). As they have quite the same function in the neutrophil, we can hypothesize that the diseases found related to those proteins are related to the diseases we might found with NSP4.&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Nevertheless, many studies have been released on the three most important neutrophil serin &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;proteases &lt;/ins&gt;: neutrophil elastase (NE), cathepsin G (CG) and proteinase 3 (PR3). As they have quite the same function in the neutrophil, we can hypothesize that the diseases found related to those proteins are related to the diseases we might found with NSP4.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;For example, instead of &lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;phagocyte &lt;/del&gt;bacteria, neutrophils can begin an alternative cell death program leading the exchange of their nuclear chromatin by extracellular chromatin fibers covered with antimicrobial protease that can kill bacteria. &amp;lt;ref&amp;gt;Neutrophil extracellular traps kill bacteria.&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;For example, instead of &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;phagocytising &lt;/ins&gt;bacteria, neutrophils can begin an alternative cell death program leading the exchange of their nuclear chromatin by extracellular chromatin fibers covered with antimicrobial protease that can kill bacteria. &amp;lt;ref&amp;gt;Neutrophil extracellular traps kill bacteria.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Brinkmann V1, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS, Weinrauch Y, Zychlinsky A. https://www.ncbi.nlm.nih.gov/pubmed/15001782&amp;lt;/ref&amp;gt; However, if neutrophils are over activated it could lead to autoimmune diseases against neutrophils serine proteases or hypersensitivity reactions. &lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Brinkmann V1, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS, Weinrauch Y, Zychlinsky A. https://www.ncbi.nlm.nih.gov/pubmed/15001782&amp;lt;/ref&amp;gt; However, if neutrophils are over activated&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;, &lt;/ins&gt;it could lead to autoimmune diseases against neutrophils serine proteases or hypersensitivity reactions. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;A disorder of neutrophil serine proteases &lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;as &lt;/del&gt;also been demonstrated in many genetic disorders like Higashi syndrome or Papillon-Lefevre syndrome.&amp;lt;ref&amp;gt;Tailor-made inflammation: how neutrophil serine proteases modulate the inflammatory response&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;A disorder of neutrophil serine proteases &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;has &lt;/ins&gt;also been demonstrated in many genetic disorders like Higashi syndrome or Papillon-Lefevre syndrome.&amp;lt;ref&amp;gt;Tailor-made inflammation: how neutrophil serine proteases modulate the inflammatory response&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Kai Kessenbrock,corresponding author1 Therese Dau,2 and Dieter E. Jenne2 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3016231/#CR2&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Kai Kessenbrock,corresponding author1 Therese Dau,2 and Dieter E. Jenne2 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3016231/#CR2&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</description>
			<pubDate>Fri, 27 Jan 2017 16:43:08 GMT</pubDate>			<dc:creator>Ophelie Lefort</dc:creator>			<comments>http://52.214.119.220/wiki/index.php/User_talk:Ophelie_Lefort/Sandbox</comments>		</item>
		<item>
			<title>Ophelie Lefort at 12:56, 27 January 2017</title>
			<link>http://52.214.119.220/wiki/index.php?title=User:Ophelie_Lefort/Sandbox&amp;diff=2712700&amp;oldid=prev</link>
			<description>&lt;p&gt;&lt;/p&gt;

			&lt;table style=&quot;background-color: white; color:black;&quot;&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;tr&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;←Older revision&lt;/td&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;Revision as of 12:56, 27 January 2017&lt;/td&gt;
			&lt;/tr&gt;
		&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 53:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 53:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== References ==&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== References ==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;[https://www.ncbi.nlm.nih.gov/pubmed/23904161] NSP4 is stored in azurophil granules and released by activated neutrophils as active endoprotease with restricted specificity, NCBI&lt;/div&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3341072/] NSP4, an elastase-related protease in human neutrophils with arginine specificity, NCBI&lt;/div&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3016231/] Tailor-made inflammation: how neutrophil serine proteases modulate the inflammatory response, NCBI&lt;/div&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;[https://www.ncbi.nlm.nih.gov/pubmed/20836000] Role of neutrophils in innate immunity: a systems biology-level approach, NCBI&lt;/div&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4783580/] Neutrophils: Their Role in Innate and Adaptive Immunity, NCBI&lt;/div&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;[https://www.ncbi.nlm.nih.gov/pubmed/15001782] Neutrophil extracellular traps kill bacteria, NCBI&lt;/div&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3016231/#CR2] Tailor-made inflammation: how neutrophil serine proteases modulate the inflammatory response, NCBI&lt;/div&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;lt;references/&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;lt;references/&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</description>
			<pubDate>Fri, 27 Jan 2017 12:56:32 GMT</pubDate>			<dc:creator>Ophelie Lefort</dc:creator>			<comments>http://52.214.119.220/wiki/index.php/User_talk:Ophelie_Lefort/Sandbox</comments>		</item>
		<item>
			<title>Ophelie Lefort at 12:51, 27 January 2017</title>
			<link>http://52.214.119.220/wiki/index.php?title=User:Ophelie_Lefort/Sandbox&amp;diff=2712698&amp;oldid=prev</link>
			<description>&lt;p&gt;&lt;/p&gt;

			&lt;table style=&quot;background-color: white; color:black;&quot;&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;tr&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;←Older revision&lt;/td&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;Revision as of 12:51, 27 January 2017&lt;/td&gt;
			&lt;/tr&gt;
		&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 36:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 36:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;In this manner, deficiency in NSP4 might lead to neutrophil deficiency and have terrible consequences. Unfortunately, NP4 is not the more important serin protease of neutrophils, so there isn’t currently in vivo studies of the release of the protein, and any disease as yet been associated with a NSP4 dysfunction.&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;In this manner, deficiency in NSP4 might lead to neutrophil deficiency and have terrible consequences. Unfortunately, NP4 is not the more important serin protease of neutrophils, so there isn’t currently in vivo studies of the release of the protein, and any disease as yet been associated with a NSP4 dysfunction.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Nevertheless, many studies have been released on the three most important neutrophil serin protease: neutrophil elastase (NE), cathepsin G (CG), and proteinase 3 (PR3). As they have quite the same function in the neutrophil, we can hypothesize that the diseases found related to those proteins are related to the diseases we might found with NSP4.&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Nevertheless, many studies have been released on the three most important neutrophil serin protease: neutrophil elastase (NE), cathepsin G (CG), and proteinase 3 (PR3). As they have quite the same function in the neutrophil, we can hypothesize that the diseases found related to those proteins are related to the diseases we might found with NSP4.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;For example, instead of phagocyte bacteria, neutrophils can begin an alternative cell death program leading the exchange of their nuclear chromatin by extracellular chromatin fibers covered with antimicrobial protease that can kill bacteria. &lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;[[&lt;/del&gt;https://www.ncbi.nlm.nih.gov/pubmed/15001782&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;]] &lt;/del&gt;However, if neutrophils are over activated it could lead to autoimmune diseases against neutrophils serine proteases or hypersensitivity reactions. &lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;For example, instead of phagocyte bacteria, neutrophils can begin an alternative cell death program leading the exchange of their nuclear chromatin by extracellular chromatin fibers covered with antimicrobial protease that can kill bacteria. &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;&amp;lt;ref&amp;gt;Neutrophil extracellular traps kill bacteria.&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;A disorder of neutrophil serine proteases as also been demonstrated in many genetic disorders like Higashi syndrome or Papillon-Lefevre syndrome.&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;[[&lt;/del&gt;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3016231/#CR2&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;]]&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;Brinkmann V1, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS, Weinrauch Y, Zychlinsky A. &lt;/ins&gt;https://www.ncbi.nlm.nih.gov/pubmed/15001782&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;&amp;lt;/ref&amp;gt; &lt;/ins&gt;However, if neutrophils are over activated it could lead to autoimmune diseases against neutrophils serine proteases or hypersensitivity reactions. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;lt;/&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;StructureSection&lt;/del&gt;&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;A disorder of neutrophil serine proteases as also been demonstrated in many genetic disorders like Higashi syndrome or Papillon-Lefevre syndrome.&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;&amp;lt;ref&amp;gt;Tailor-made inflammation: how neutrophil serine proteases modulate the inflammatory response&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;Kai Kessenbrock,corresponding author1 Therese Dau,2 and Dieter E. Jenne2 &lt;/ins&gt;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3016231/#CR2&amp;lt;/&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;ref&lt;/ins&gt;&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</description>
			<pubDate>Fri, 27 Jan 2017 12:51:44 GMT</pubDate>			<dc:creator>Ophelie Lefort</dc:creator>			<comments>http://52.214.119.220/wiki/index.php/User_talk:Ophelie_Lefort/Sandbox</comments>		</item>
		<item>
			<title>Ophelie Lefort at 12:45, 27 January 2017</title>
			<link>http://52.214.119.220/wiki/index.php?title=User:Ophelie_Lefort/Sandbox&amp;diff=2712695&amp;oldid=prev</link>
			<description>&lt;p&gt;&lt;/p&gt;

			&lt;table style=&quot;background-color: white; color:black;&quot;&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;tr&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;←Older revision&lt;/td&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;Revision as of 12:45, 27 January 2017&lt;/td&gt;
			&lt;/tr&gt;
		&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 31:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 31:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== Disease ==&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== Disease ==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Granulocytes neutrophils are the most abundant leukocytes in the blood and are implicated in the immune system. They are the first defend barriers in the innate immunity. When a pathogen agent enters into the body, they recognize it thanks to its antigens and phagocyte the pathogen. They are quick and their recognition is non-specific, and not dependent on previous exposure to microorganisms.&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;[[&lt;/del&gt;https://www.ncbi.nlm.nih.gov/pubmed/20836000&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;]] &lt;/del&gt;It has also been shown that neutrophils have not only a phagocyte role but can influence all the innate and adaptive immune response by exchanging information with the other immune cells through soluble mediators or direct cell contact.&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;[[&lt;/del&gt;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4783580/&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;]]&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Granulocytes neutrophils are the most abundant leukocytes in the blood and are implicated in the immune system. They are the first defend barriers in the innate immunity. When a pathogen agent enters into the body, they recognize it thanks to its antigens and phagocyte the pathogen. They are quick and their recognition is non-specific, and not dependent on previous exposure to microorganisms.&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;&amp;lt;ref&amp;gt;Role of neutrophils in innate immunity: a systems biology-level approach.&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;Kobayashi SD1, DeLeo FR. &lt;/ins&gt;https://www.ncbi.nlm.nih.gov/pubmed/20836000&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;&amp;lt;/ref&amp;gt; &lt;/ins&gt;It has also been shown that neutrophils have not only a phagocyte role but can influence all the innate and adaptive immune response by exchanging information with the other immune cells through soluble mediators or direct cell contact.&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;&amp;lt;ref&amp;gt;Neutrophils: Their Role in Innate and Adaptive Immunity&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;Carlos Rosales, 1 , * Nicolas Demaurex, 2 Clifford A. Lowell, 3 and Eileen Uribe-Querol 4  &lt;/ins&gt;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4783580/&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;&amp;lt;/ref&amp;gt;&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;In this manner, deficiency in NSP4 might lead to neutrophil deficiency and have terrible consequences. Unfortunately, NP4 is not the more important serin protease of neutrophils, so there isn’t currently in vivo studies of the release of the protein, and any disease as yet been associated with a NSP4 dysfunction.&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;In this manner, deficiency in NSP4 might lead to neutrophil deficiency and have terrible consequences. Unfortunately, NP4 is not the more important serin protease of neutrophils, so there isn’t currently in vivo studies of the release of the protein, and any disease as yet been associated with a NSP4 dysfunction.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Nevertheless, many studies have been released on the three most important neutrophil serin protease: neutrophil elastase (NE), cathepsin G (CG), and proteinase 3 (PR3). As they have quite the same function in the neutrophil, we can hypothesize that the diseases found related to those proteins are related to the diseases we might found with NSP4.&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Nevertheless, many studies have been released on the three most important neutrophil serin protease: neutrophil elastase (NE), cathepsin G (CG), and proteinase 3 (PR3). As they have quite the same function in the neutrophil, we can hypothesize that the diseases found related to those proteins are related to the diseases we might found with NSP4.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</description>
			<pubDate>Fri, 27 Jan 2017 12:45:59 GMT</pubDate>			<dc:creator>Ophelie Lefort</dc:creator>			<comments>http://52.214.119.220/wiki/index.php/User_talk:Ophelie_Lefort/Sandbox</comments>		</item>
		<item>
			<title>Ophelie Lefort at 12:35, 27 January 2017</title>
			<link>http://52.214.119.220/wiki/index.php?title=User:Ophelie_Lefort/Sandbox&amp;diff=2712685&amp;oldid=prev</link>
			<description>&lt;p&gt;&lt;/p&gt;

			&lt;table style=&quot;background-color: white; color:black;&quot;&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;tr&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;←Older revision&lt;/td&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;Revision as of 12:35, 27 January 2017&lt;/td&gt;
			&lt;/tr&gt;
		&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 13:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 13:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== Structural highlights ==&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== Structural highlights ==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;The protein has a 283 amino-acids long sequence with two mainly domains [[Image:Linear structure of PRSS57.png | thumb]]. It forms a kind of elongate sphere of approximately 70Å large and 150Å long (dimensions: 70,37Å X 70,37Å X 105,02Å). The protein is composed of signal peptide (1-31) which leads to the location in azurophil granules &lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;[http&lt;/del&gt;://&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;www.jimmunol&lt;/del&gt;.org/&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;content&lt;/del&gt;/&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;191/5&lt;/del&gt;/&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;2700] &lt;/del&gt;and allows its excretion. In addition there is a protease domain (32-283) which is a trypsin-like domain with a trypsin-like &amp;lt;scene name='75/751133/Active_site/1'&amp;gt;active site&amp;lt;/scene&amp;gt; , according to the specificity for P1-Arg residues, but this domain can be an elastase-like active site according to the primary sequence (because of the presence of a swallow S1 pocket) specific to small aliphatic residues.&amp;lt;ref&amp;gt;S.. Jack Lin, Ken C. Dong, Charles Eigenbrot, Menno van Lookeren Campagne, Daniel Kirchhofer Structures of Neutrophil Serine Protease 4 Reveal an Unusual Mechanism of Substrate Recognition by a Trypsin-Fold Protease DOI: http://dx.doi.org/10.1016/j.str.2014.07.008&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;The protein has a 283 amino-acids long sequence with two mainly domains [[Image:Linear structure of PRSS57.png | thumb]]. It forms a kind of elongate sphere of approximately 70Å large and 150Å long (dimensions: 70,37Å X 70,37Å X 105,02Å). The protein is composed of signal peptide (1-31) which leads to the location in azurophil granules &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;&amp;lt;ref&amp;gt;NSP4 Is Stored in Azurophil Granules and Released by Activated Neutrophils as Active Endoprotease with Restricted Specificity&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;Natascha C. Perera, Karl-Heinz Wiesmüller, Maria Torp Larsen, Beate Schacher, Peter Eickholz, Niels Borregaard and Dieter E. Jenne DOI: https&lt;/ins&gt;://&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;doi&lt;/ins&gt;.org/&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;10.4049&lt;/ins&gt;/&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;jimmunol.1301293 &amp;lt;&lt;/ins&gt;/&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;ref&amp;gt; &lt;/ins&gt;and allows its excretion. In addition there is a protease domain (32-283) which is a trypsin-like domain with a trypsin-like &amp;lt;scene name='75/751133/Active_site/1'&amp;gt;active site&amp;lt;/scene&amp;gt; , according to the specificity for P1-Arg residues, but this domain can be an elastase-like active site according to the primary sequence (because of the presence of a swallow S1 pocket) specific to small aliphatic residues.&amp;lt;ref&amp;gt;S.. Jack Lin, Ken C. Dong, Charles Eigenbrot, Menno van Lookeren Campagne, Daniel Kirchhofer Structures of Neutrophil Serine Protease 4 Reveal an Unusual Mechanism of Substrate Recognition by a Trypsin-Fold Protease DOI: http://dx.doi.org/10.1016/j.str.2014.07.008&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;The &amp;lt;scene name='75/751133/Active_site/1'&amp;gt;active site&amp;lt;/scene&amp;gt; is form by 4 amino acids: Gly(189), Phe(190), Ser(216), D(226)&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;The &amp;lt;scene name='75/751133/Active_site/1'&amp;gt;active site&amp;lt;/scene&amp;gt; is form by 4 amino acids: Gly(189), Phe(190), Ser(216), D(226)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;The residue F190 obstructs the active site which could normally not links a P1-Arg. However, a study &amp;lt;ref&amp;gt;Natascha C. Perera, Karl-Heinz Wiesmüller, Maria Torp Larsen, Beate Schacher, Peter Eickholz, Niels Borregaard and Dieter E. Jenne NSP4 Is Stored in Azurophil Granules and Released by Activated Neutrophils as Active Endoprotease with Restricted Specificity  DOI: https://doi.org/10.4049/jimmunol.1301293&amp;lt;/ref&amp;gt; considered the possibility that the two residues S216 and F190 of the active site can form a flexible gate which allows P1-Arg to enter. Then, the link between the active site and P1-Arg can be stabilized by a salt bridge interaction between S1-D226 and P1-Arg.&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;The residue F190 obstructs the active site which could normally not links a P1-Arg. However, a study &amp;lt;ref&amp;gt;Natascha C. Perera, Karl-Heinz Wiesmüller, Maria Torp Larsen, Beate Schacher, Peter Eickholz, Niels Borregaard and Dieter E. Jenne NSP4 Is Stored in Azurophil Granules and Released by Activated Neutrophils as Active Endoprotease with Restricted Specificity  DOI: https://doi.org/10.4049/jimmunol.1301293&amp;lt;/ref&amp;gt; considered the possibility that the two residues S216 and F190 of the active site can form a flexible gate which allows P1-Arg to enter. Then, the link between the active site and P1-Arg can be stabilized by a salt bridge interaction between S1-D226 and P1-Arg.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</description>
			<pubDate>Fri, 27 Jan 2017 12:35:53 GMT</pubDate>			<dc:creator>Ophelie Lefort</dc:creator>			<comments>http://52.214.119.220/wiki/index.php/User_talk:Ophelie_Lefort/Sandbox</comments>		</item>
		<item>
			<title>Ophelie Lefort at 12:30, 27 January 2017</title>
			<link>http://52.214.119.220/wiki/index.php?title=User:Ophelie_Lefort/Sandbox&amp;diff=2712679&amp;oldid=prev</link>
			<description>&lt;p&gt;&lt;/p&gt;

			&lt;table style=&quot;background-color: white; color:black;&quot;&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;tr&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;←Older revision&lt;/td&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;Revision as of 12:30, 27 January 2017&lt;/td&gt;
			&lt;/tr&gt;
		&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 7:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 7:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Recruitement of neutrophils to the site of inflammation is the earliest defense reaction against pathogens. NSP4 is stored in the azurophilic granules &amp;lt;ref&amp;gt;PMID:23904161&amp;lt;/ref&amp;gt; which is a compartment of neutrophils. In response to neutrophil activation, NSP4 is released into the pericellular environment where microbes are after their phagocytosis. The serine protease 54 not only kill pathogens but also regulate the activity of immune mediators such as chemokines and lymphocytes. &amp;lt;ref&amp;gt;NSP4, an elastase-related protease in human neutrophils with arginine specificity&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Recruitement of neutrophils to the site of inflammation is the earliest defense reaction against pathogens. NSP4 is stored in the azurophilic granules &amp;lt;ref&amp;gt;PMID:23904161&amp;lt;/ref&amp;gt; which is a compartment of neutrophils. In response to neutrophil activation, NSP4 is released into the pericellular environment where microbes are after their phagocytosis. The serine protease 54 not only kill pathogens but also regulate the activity of immune mediators such as chemokines and lymphocytes. &amp;lt;ref&amp;gt;NSP4, an elastase-related protease in human neutrophils with arginine specificity&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Natascha C. Perera,a Oliver Schilling,b Heike Kittel,a Walter Back,c Elisabeth Kremmer,d and Dieter E. Jenne &lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;doi&lt;/del&gt;: &lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;10.1073&lt;/del&gt;/&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;pnas&lt;/del&gt;.&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;1200470109&lt;/del&gt;&amp;lt;/ref&amp;gt; NSP4 alterates chemokines by proteolitically cleaving N-terminus of the chemokine.&amp;lt;ref&amp;gt;&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;PMC&lt;/del&gt;:&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;3016231&lt;/del&gt;&amp;lt;/ref&amp;gt; Furthermore, the caspase-like activity of PRSS57 can activate lymphocytes and the adaptive immune response. However, although NSP4 can inactivate some inflammatory processes, the neutrophil serine protease generally promotes than inhibits the inflammatory response.&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Natascha C. Perera,a Oliver Schilling,b Heike Kittel,a Walter Back,c Elisabeth Kremmer,d and Dieter E. Jenne &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;https&lt;/ins&gt;:/&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;/www&lt;/ins&gt;.&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;ncbi.nlm.nih.gov/pmc/articles/PMC3341072/&lt;/ins&gt;&amp;lt;/ref&amp;gt; NSP4 alterates chemokines by proteolitically cleaving N-terminus of the chemokine.&amp;lt;ref&amp;gt;&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;ailor-made inflammation&lt;/ins&gt;: &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;how neutrophil serine proteases modulate the inflammatory response&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;Kai Kessenbrock,corresponding author1 Therese Dau,2 and Dieter E. Jenne2 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3016231/&lt;/ins&gt;&amp;lt;/ref&amp;gt; Furthermore, the caspase-like activity of PRSS57 can activate lymphocytes and the adaptive immune response. However, although NSP4 can inactivate some inflammatory processes, the neutrophil serine protease generally promotes than inhibits the inflammatory response.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</description>
			<pubDate>Fri, 27 Jan 2017 12:30:55 GMT</pubDate>			<dc:creator>Ophelie Lefort</dc:creator>			<comments>http://52.214.119.220/wiki/index.php/User_talk:Ophelie_Lefort/Sandbox</comments>		</item>
		<item>
			<title>Ophelie Lefort at 12:29, 27 January 2017</title>
			<link>http://52.214.119.220/wiki/index.php?title=User:Ophelie_Lefort/Sandbox&amp;diff=2712678&amp;oldid=prev</link>
			<description>&lt;p&gt;&lt;/p&gt;

			&lt;table style=&quot;background-color: white; color:black;&quot;&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;tr&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;←Older revision&lt;/td&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;Revision as of 12:29, 27 January 2017&lt;/td&gt;
			&lt;/tr&gt;
		&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 7:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 7:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Recruitement of neutrophils to the site of inflammation is the earliest defense reaction against pathogens. NSP4 is stored in the azurophilic granules &amp;lt;ref&amp;gt;PMID:23904161&amp;lt;/ref&amp;gt; which is a compartment of neutrophils. In response to neutrophil activation, NSP4 is released into the pericellular environment where microbes are after their phagocytosis. The serine protease 54 not only kill pathogens but also regulate the activity of immune mediators such as chemokines and lymphocytes. &amp;lt;ref&amp;gt;NSP4, an elastase-related protease in human neutrophils with arginine specificity&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Recruitement of neutrophils to the site of inflammation is the earliest defense reaction against pathogens. NSP4 is stored in the azurophilic granules &amp;lt;ref&amp;gt;PMID:23904161&amp;lt;/ref&amp;gt; which is a compartment of neutrophils. In response to neutrophil activation, NSP4 is released into the pericellular environment where microbes are after their phagocytosis. The serine protease 54 not only kill pathogens but also regulate the activity of immune mediators such as chemokines and lymphocytes. &amp;lt;ref&amp;gt;NSP4, an elastase-related protease in human neutrophils with arginine specificity&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Natascha C. Perera,a Oliver Schilling,b Heike Kittel,a Walter Back,c Elisabeth Kremmer,d and Dieter E. Jenne doi:10.1073/pnas.1200470109&amp;lt;/ref&amp;gt; NSP4 alterates chemokines by proteolitically cleaving N-terminus of the chemokine.&amp;lt;ref&amp;gt;PMC:3016231&amp;lt;/ref&amp;gt; Furthermore, the caspase-like activity of PRSS57 can activate lymphocytes and the adaptive immune response. However, although NSP4 can inactivate some inflammatory processes, the neutrophil serine protease generally promotes than inhibits the inflammatory response.&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Natascha C. Perera,a Oliver Schilling,b Heike Kittel,a Walter Back,c Elisabeth Kremmer,d and Dieter E. Jenne doi: 10.1073/pnas.1200470109&amp;lt;/ref&amp;gt; NSP4 alterates chemokines by proteolitically cleaving N-terminus of the chemokine.&amp;lt;ref&amp;gt;PMC:3016231&amp;lt;/ref&amp;gt; Furthermore, the caspase-like activity of PRSS57 can activate lymphocytes and the adaptive immune response. However, although NSP4 can inactivate some inflammatory processes, the neutrophil serine protease generally promotes than inhibits the inflammatory response.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</description>
			<pubDate>Fri, 27 Jan 2017 12:29:19 GMT</pubDate>			<dc:creator>Ophelie Lefort</dc:creator>			<comments>http://52.214.119.220/wiki/index.php/User_talk:Ophelie_Lefort/Sandbox</comments>		</item>
		<item>
			<title>Ophelie Lefort at 12:26, 27 January 2017</title>
			<link>http://52.214.119.220/wiki/index.php?title=User:Ophelie_Lefort/Sandbox&amp;diff=2712677&amp;oldid=prev</link>
			<description>&lt;p&gt;&lt;/p&gt;

			&lt;table style=&quot;background-color: white; color:black;&quot;&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;tr&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;←Older revision&lt;/td&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;Revision as of 12:26, 27 January 2017&lt;/td&gt;
			&lt;/tr&gt;
		&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 6:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 6:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;==Function==&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;==Function==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Recruitement of neutrophils to the site of inflammation is the earliest defense reaction against pathogens. NSP4 is stored in the azurophilic granules &amp;lt;ref&amp;gt;PMID:23904161&amp;lt;/ref&amp;gt; which is a compartment of neutrophils. In response to neutrophil activation, NSP4 is released into the pericellular environment where microbes are after their phagocytosis. The serine protease 54 not only kill pathogens but also regulate the activity of immune mediators such as chemokines and lymphocytes. &amp;lt;ref&amp;gt;&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;PMC&lt;/del&gt;:&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;3341072&lt;/del&gt;&amp;lt;/ref&amp;gt; NSP4 alterates chemokines by proteolitically cleaving N-terminus of the chemokine.&amp;lt;ref&amp;gt;PMC:3016231&amp;lt;/ref&amp;gt; Furthermore, the caspase-like activity of PRSS57 can activate lymphocytes and the adaptive immune response. However, although NSP4 can inactivate some inflammatory processes, the neutrophil serine protease generally promotes than inhibits the inflammatory response.&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Recruitement of neutrophils to the site of inflammation is the earliest defense reaction against pathogens. NSP4 is stored in the azurophilic granules &amp;lt;ref&amp;gt;PMID:23904161&amp;lt;/ref&amp;gt; which is a compartment of neutrophils. In response to neutrophil activation, NSP4 is released into the pericellular environment where microbes are after their phagocytosis. The serine protease 54 not only kill pathogens but also regulate the activity of immune mediators such as chemokines and lymphocytes. &amp;lt;ref&amp;gt;&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;NSP4, an elastase-related protease in human neutrophils with arginine specificity&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;Natascha C. Perera,a Oliver Schilling,b Heike Kittel,a Walter Back,c Elisabeth Kremmer,d and Dieter E. Jenne doi&lt;/ins&gt;:&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;10.1073/pnas.1200470109&lt;/ins&gt;&amp;lt;/ref&amp;gt; NSP4 alterates chemokines by proteolitically cleaving N-terminus of the chemokine.&amp;lt;ref&amp;gt;PMC:3016231&amp;lt;/ref&amp;gt; Furthermore, the caspase-like activity of PRSS57 can activate lymphocytes and the adaptive immune response. However, although NSP4 can inactivate some inflammatory processes, the neutrophil serine protease generally promotes than inhibits the inflammatory response.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</description>
			<pubDate>Fri, 27 Jan 2017 12:26:50 GMT</pubDate>			<dc:creator>Ophelie Lefort</dc:creator>			<comments>http://52.214.119.220/wiki/index.php/User_talk:Ophelie_Lefort/Sandbox</comments>		</item>
		<item>
			<title>Ophelie Lefort at 12:25, 27 January 2017</title>
			<link>http://52.214.119.220/wiki/index.php?title=User:Ophelie_Lefort/Sandbox&amp;diff=2712675&amp;oldid=prev</link>
			<description>&lt;p&gt;&lt;/p&gt;

			&lt;table style=&quot;background-color: white; color:black;&quot;&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;tr&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;←Older revision&lt;/td&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;Revision as of 12:25, 27 January 2017&lt;/td&gt;
			&lt;/tr&gt;
		&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 6:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 6:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;==Function==&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;==Function==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Recruitement of neutrophils to the site of inflammation is the earliest defense reaction against pathogens. NSP4 is stored in the azurophilic granules &amp;lt;ref&amp;gt;PMID:23904161&amp;lt;/ref&amp;gt; which is a compartment of neutrophils. In response to neutrophil activation, NSP4 is released into the pericellular environment where microbes are after their phagocytosis. The serine protease 54 not only kill pathogens but also regulate the activity of immune mediators such as chemokines and lymphocytes. &amp;lt;ref&amp;gt;&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;PMC3341072&lt;/del&gt;&amp;lt;/ref&amp;gt; NSP4 alterates chemokines by proteolitically cleaving N-terminus of the chemokine.&amp;lt;ref&amp;gt;&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;PMC3016231&lt;/del&gt;&amp;lt;/ref&amp;gt; Furthermore, the caspase-like activity of PRSS57 can activate lymphocytes and the adaptive immune response. However, although NSP4 can inactivate some inflammatory processes, the neutrophil serine protease generally promotes than inhibits the inflammatory response.&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Recruitement of neutrophils to the site of inflammation is the earliest defense reaction against pathogens. NSP4 is stored in the azurophilic granules &amp;lt;ref&amp;gt;PMID:23904161&amp;lt;/ref&amp;gt; which is a compartment of neutrophils. In response to neutrophil activation, NSP4 is released into the pericellular environment where microbes are after their phagocytosis. The serine protease 54 not only kill pathogens but also regulate the activity of immune mediators such as chemokines and lymphocytes. &amp;lt;ref&amp;gt;&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;PMC:3341072&lt;/ins&gt;&amp;lt;/ref&amp;gt; NSP4 alterates chemokines by proteolitically cleaving N-terminus of the chemokine.&amp;lt;ref&amp;gt;&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;PMC:3016231&lt;/ins&gt;&amp;lt;/ref&amp;gt; Furthermore, the caspase-like activity of PRSS57 can activate lymphocytes and the adaptive immune response. However, although NSP4 can inactivate some inflammatory processes, the neutrophil serine protease generally promotes than inhibits the inflammatory response.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</description>
			<pubDate>Fri, 27 Jan 2017 12:25:18 GMT</pubDate>			<dc:creator>Ophelie Lefort</dc:creator>			<comments>http://52.214.119.220/wiki/index.php/User_talk:Ophelie_Lefort/Sandbox</comments>		</item>
	</channel>
</rss>